Biotech 2050 Podcast cover image

107. Fighting infectious diseases with biologics, Paul Garofolo, Co-founder & CEO, Locus Biosciences

Biotech 2050 Podcast

00:00

The Biggest Learning From Patheon and Arndy

I think it's muh more of a margin centric game on the services side. When you're in a bigger farma company where you have a vast portfolio, efcuse around the world,. It has a sense of sort of selling everything from dermitology products to neuralogy drugs. But there's a big skew bas so, you know, you have a lot of these different types of dynamics of managing a big catalogue of drugs. I'll give you one that people are really, i think, always shocked about: 85 % of drugs experience at least a 12 to 14 month delay because of c m c hiccups.

Play episode from 02:11
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app